Pascal Biosciences Overview

  • Status
  • Public
  • Employees
  • 6
Employees
  • Stock Symbol
  • PAS
Stock Symbol
  • Share Price
  • $0.09
  • (As of Friday Closing)

Pascal Biosciences General Information

Description

Pascal Biosciences Inc is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system. The company has one operating segment, biotechnology research and development with lab and computer equipment in the United States of America.

Contact Information

Formerly Known As
BioMmune Technologies
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
TSX
Primary Office
  • Box 352141
  • Suite 304, Fluke Hall, 4000 Mason Road
  • Seattle, WA 98195-2141
  • United States
+1 (206) 000-0000

Pascal Biosciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pascal Biosciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.09 $0.09 $0.06 - $0.33 $6.15M 65.1M 73.2K -$0.02

Pascal Biosciences Financials Summary

In Thousands,
USD
TTM 28-Feb-2021 FY 2020 30-Nov-2020 FY 2019 30-Nov-2019 FY 2018 30-Nov-2018
EV 5,108 7,053 2,092 6,593
Revenue 0 0 0 0
EBITDA (675) (906) (2,563) (2,459)
Net Income (676) (920) (2,566) (2,514)
Total Assets 410 93 343 2,876
Total Debt 119 113 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pascal Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pascal Biosciences‘s full profile, request access.

Request a free trial

Pascal Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Patrick Gray Ph.D Chief Executive Officer & Board Member
Judi Dalling Chief Financial Officer
Kevin Egan Vice President
Larry Tjoelker Ph.D Vice President
You’re viewing 4 of 5 executive team members. Get the full list »

Pascal Biosciences Board Members (3)

Name Representing Role Since
0000 0000000000 Pascal Biosciences Board Member 000 0000
0000000 0000 00.0 Pascal Biosciences Chief Executive Officer & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Pascal Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pascal Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pascal Biosciences‘s full profile, request access.

Request a free trial